Department of Radiology, Wayne State University, School of Medicine, Detroit, MI, USA.
Department of Radiology, Wayne State University, School of Medicine, Detroit, MI, USA.
Clin Imaging. 2021 Mar;71:17-23. doi: 10.1016/j.clinimag.2020.11.004. Epub 2020 Nov 5.
Aim is to assess the temporal changes and prognostic value of chest radiograph (CXR) in COVID-19 patients.
We performed a retrospective study of confirmed COVID-19 patients presented to the emergency between March 07-17, 2020. Clinical & radiological findings were reviewed. Clinical outcomes were classified into critical & non-critical based on severity. Two independent radiologists graded frontal view CXRs into COVID-19 pneumonia category 1 (CoV-P1) with <4 zones and CoV-P2 with ≥4 zones involvement. Interobserver agreement of CoV-P category for the CXR preceding the clinical outcome was assessed using Kendall's τ coefficient. Association between CXR findings and clinical deterioration was calculated along with temporal changes of CXR findings with disease progression.
Sixty-two patients were evaluated for clinical features. 56 of these (total: 325 CXRs) were evaluated for radiological findings. Common patterns were progression from lower to upper zones, peripheral to diffuse involvement, & from ground glass opacities to consolidation. Consolidations starting peripherally were noted in 76%, 93% and 48% with critical outcomes, respectively. The interobserver agreement of the CoV-P category of CXRs in the critical and non-critical outcome groups were good and excellent, respectively (τ coefficient = 0.6 & 1.0). Significant association was observed between CoV-P2 and clinical deterioration into a critical status (χ2 = 27.7, p = 0.0001) with high sensitivity (95%) and specificity (71%) within a median interval time of 2 days (range: 0-4 days).
Involvement of predominantly 4 or more zones on frontal chest radiograph can be used as predictive prognostic indicator of poorer outcome in COVID-19 patients.
评估 COVID-19 患者的胸部 X 线(CXR)的时间变化和预后价值。
我们对 2020 年 3 月 7 日至 17 日期间在急诊就诊的确诊 COVID-19 患者进行了回顾性研究。回顾了临床和放射学发现。根据严重程度将临床结果分为危急和非危急。两名独立的放射科医生将正位胸片的 CXR 分为 COVID-19 肺炎 1 类(CoV-P1),累及<4 个区和 CoV-P2,累及≥4 个区。使用 Kendall's τ 系数评估 CXR 结果与临床结果之前的 CoV-P 分类的观察者间一致性。计算了 CXR 结果与临床恶化之间的相关性,以及 CXR 结果随疾病进展的时间变化。
对 62 例患者的临床特征进行了评估。其中 56 例(总共有 325 张 CXR)进行了放射学发现评估。常见的模式是从下至上区、从外周至弥漫性、从磨玻璃影到实变进展。在危急结局中,分别有 76%、93%和 48%的患者从外周开始出现实变。在危急和非危急结局组中,CXR 的 CoV-P 分类的观察者间一致性良好和优秀(τ系数分别为 0.6 和 1.0)。在 CoV-P2 与临床恶化至危急状态之间观察到显著相关性(χ2=27.7,p=0.0001),其敏感性(95%)和特异性(71%)均较高,中位间隔时间为 2 天(范围:0-4 天)。
在前胸正位 X 线片上主要累及 4 个或更多区域可作为 COVID-19 患者预后不良的预测性预后指标。